I just may always be bigger than what society says average is, which I'm okay with
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (surpass-3 MRI): A substudy of the randomised, open-label, parallel-group, phase 3 surpass-3 trial
Burillo J, Marques P, Jimenez B, Gonzalez-Blanco C, Benito M, Guillen C
Early-phase clinical trial data, including results from a Phase 2 trial published in the New England Journal of Medicine in 2023, demonstrated mean weight loss of up to approximately 24% of baseline body weight at 48 weeks in adults with obesity who did not have type 2 diabetes
20 Thus, drugs utilising GIP, GLP-1, or GLP-2 receptor signalling pathways are already in clinical use, which should make potential application within the bone disease arena less complicated ( Figure 3 )